What are the risks of investing in OABI?
O
What are the risks of investing in OABI?
🦉
OmniAb, Inc. (OABI)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOMatthew W. Foehr
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics....
Key Executives
| Name | Title |
|---|---|
| Bill Harriman | Senior Vice President of Antibody Discovery |
| Bob Chen | Senior Vice President of Discovery Systems |
| Charles S. Berkman | Chief Legal Officer & Secretary |
| Christel Iffland | Senior Vice President of Antibody Technologies |
| Cia McCaffrey | Senior Vice President of People & Talent |
| Kurt A. Gustafson | Executive Vice President of Finance & Chief Financial Officer |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A